# Topical Sevoflurane for Treatment of Chronic Leg Ulcers

> **NCT05303805** · PHASE4 · RECRUITING · sponsor: **Charles University, Czech Republic** · enrollment: 50 (estimated)

## Conditions studied

- Leg Ulcer

## Interventions

- **DRUG:** Sevoflurane
- **COMBINATION_PRODUCT:** Cyteal

## Key facts

- **NCT ID:** NCT05303805
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-02
- **Primary completion:** 2026-04-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303805, "Topical Sevoflurane for Treatment of Chronic Leg Ulcers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05303805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*